Quotient Sciences, a global drug development and manufacturing accelerator, installed Centillion’s Biofoundry-in-a-Box (BiaB), the first multi-product GMP platform technology for end to end RNA manufacture.   BiaB is a modular, integrated, and automated RNA-micro factory designed to enable the end-to-end production of various RNA-based products, including messenger RNA (mRNA) and self-amplifying RNA (saRNA), and has the potential to significantly reduce the time it takes to bring RNA therapies...